46
PROPTOSIS IN PEDIATRIC PATIENTS prospective study by DR VIJAYLAXMI SHRIVASTAVA DR G. MALINI JAWAHARLAL NEHRU HOSPITAL & RESEARCH CENTRE STEEL PLANT HOSPITAL

Proptosis in pediatrics

Embed Size (px)

Citation preview

Page 1: Proptosis in pediatrics

PROPTOSIS IN PEDIATRIC PATIENTS

prospective study by DR VIJAYLAXMI SHRIVASTAVA DR G. MALINI

JAWAHARLAL NEHRU HOSPITAL & RESEARCH CENTRE STEEL PLANT HOSPITAL

Page 2: Proptosis in pediatrics

INTRODUCTION

• ANTERIOR DISPLACEMENT OF GLOBE OF EYE BY >20 mm

• >2mm DIFFERENCE BETWEEN APEX OF CORNEA OF TWO EYES

• CHILD WITH PROPTOSIS IS GROTESQUE TO LOOK AT

Page 3: Proptosis in pediatrics

INTRODUCTION

PERMANENT SEQUELAE

• CORNEAL ULCERATION• CORNEAL OPACITY• OPTIC ATROPHY• BLINDNESS

Page 4: Proptosis in pediatrics

INTRODUCTION

PROPTOSIS

OPTHALMOLOGISTOTOLARYNGOLOGIST

RADIOLOGIST

PATHOLOGIST NEUROSURGEON

CLINICIANPROPTOSIS

ONCOLOGIST

Page 5: Proptosis in pediatrics

AIMS & OBJECTIVES

TO ANALYSE• INCIDENCE• ETIOLOGICAL FACTORS• CORRELATION WITH

INVESTIGATIONAL MODALTIES• MANAGEMENT & OUTCOME

OF CHILDHOOD PROPTOSIS

Page 6: Proptosis in pediatrics

MATERIALS & METHODS

• PROSPECTIVE STUDY• DURATION:THE CALENDER YEAR 2007.• CASES WITH PROPTOSIS ADMITTED IN THE

PEDIATRICS WARD DURING ABOVE PERIOD

Page 7: Proptosis in pediatrics

MATERIALS & METHODS

• HISTORY• EXAMINATION• INVESTIGATION• MANAGEMENT• FOLLOW UP

Page 8: Proptosis in pediatrics

OBSERVATIONS

0

1

2

NU

MB

ER

6 MONTHS 4 YEAR 8 YEAR 9 YEAR 13 YEAR

AGE DISTRIBUTION

MOST CASES WERE TODDLERS - 4/7

Page 9: Proptosis in pediatrics

• TOTAL n= 7 • MALE 5/7

SEX DISTRIBUTION

2

5

FEMALE

MALE

OBSERVATIONS CONTD

Page 10: Proptosis in pediatrics

• TOTAL n=7

2

5

BILATERALUNILATERAL

OBSERVATIONS CONTD:

Page 11: Proptosis in pediatrics

PRESENTING COMPLAINTS

5 53 2

01234567

HEADACHE PAIN FEVER VOMITING

Page 12: Proptosis in pediatrics

DURATION OF COMPLAINTS

1512

108

7

52

0123456789

101112131415

DAYS

Page 13: Proptosis in pediatrics

PREDISPOSING FACTOR

SINUSITIS-ETHMOIDAL, SPHENOIDAL, & MAXILLARY

3

FURUNCULOSIS OF NOSE 1UPPER RESPIRATORY TRACT INFECTION

1

DENTAL CARIES 1

CONJUCTIVITIS 1

Page 14: Proptosis in pediatrics
Page 15: Proptosis in pediatrics
Page 16: Proptosis in pediatrics

SIGNS

LID EDEMA CHEMOSIS MENINGEALSIGNS

6 N PALSY 4 N PALSY 3 N PALSY CONVULSION

7

4 4

3 3

2

1

0

1

2

3

4

5

6

7

Page 17: Proptosis in pediatrics
Page 18: Proptosis in pediatrics
Page 19: Proptosis in pediatrics
Page 20: Proptosis in pediatrics

PUPILLARY REACTION

34

NORMAL

DILATED & SLUGGISH REACTION TO LIGHT

4/7

Page 21: Proptosis in pediatrics

FUNDUS EXAMINATION

4

3

NORMAL PAPILLEDEMA

3/7

Page 22: Proptosis in pediatrics
Page 23: Proptosis in pediatrics

INVESTIGATIONS

• HEMOGRAM• BLOOD CULTURE & SENSITIVITY• PUS/SWAB CULTURE & SENSITIVITY• CT SCAN HEAD

Page 24: Proptosis in pediatrics

INVESTIGATIONS

SPECIAL• COAGULATION PROFILE• MANTOUX TEST• ELECTROPHORESIS• CSF STUDY• PROTEIN C ,PROTEIN S LEVELS

Page 25: Proptosis in pediatrics

ETIOLOGY

33

1

3

0

1

2

3

4

5ORBITAL CELLULITIS WITHSINUSITIS WITH CAVERNOUS SINUSTHROMBOSISORBITAL CELLULITIS

RHABDOMYOSARCOMA

PROTHROMBOTIC DISORDER

Page 26: Proptosis in pediatrics

CAVERNOUS SINUS THROMBOSIS

Page 27: Proptosis in pediatrics

ORBITAL CELLULITIS

ORBITAL CELLULITIS

Page 28: Proptosis in pediatrics

RHABDOMYOSARCOMA

Page 29: Proptosis in pediatrics

MANAGEMENT

• CONSERVATIVE• SURGICAL INTERVENTION• CHEMOTHERAPY

Page 30: Proptosis in pediatrics

CONSERVATIVE MANAGEMENT

• MANAGEMENT OF SHOCK• AGGRESSIVE ANTIBIOTIC COVERAGE • TOPICAL ANTIBIOTICS & EYE CARE• LMWH(ENOXAPARIN)- IN 1 CASE OF

CAVERNOUS SINUS THROMBOSIS• SUPPORTIVE THERAPY

Page 31: Proptosis in pediatrics

ONCOLOGICL MANAGEMENT

CHEMOTHERAPY

VAC - VINCRISTINE

-ACTINOMYCIN

- CYCLOPHOSPHAMIDE

Page 32: Proptosis in pediatrics

SURGICAL MANAGEMENT

• INCISION & DRAINAGE OF ABSCESS• CRANIOTOMY & EVACUATION OF PUS• SINUS DRAINAGE • EXTRACTION OF CARIES TEETH

Page 33: Proptosis in pediatrics

COMPLICATIONS

COMPLICATIONS RATE OTHER STUDIES

OUR STUDY

VISUAL IMPAIRMENT 10-30% 14%

CAVERNOUS SINUS THROMBOSIS

40% 42%

NEUROLOGICAL DEFICIT

50% 14%

Page 34: Proptosis in pediatrics
Page 35: Proptosis in pediatrics

NO COMPLICATIONS ON FOLLOW UP

Page 36: Proptosis in pediatrics

CRANIAL NERVE PALSY WITH VISUAL IMPAIRMENT

Page 37: Proptosis in pediatrics

DISCUSSION

STUDY COMPARISON DATA

MALE :FEMALE RATIO

2.5:1 AGRAWAL etal(1979)

1.9%

BELMEKKI (1999)

2%

NAGESWARAN etal(2006)

2.7%.

SEEMA etal (2006) 1.6%

Page 38: Proptosis in pediatrics

DISCUSSION

STUDY COMPARISON DATA

AGE LESS THAN 5 YEARS

57% AGRAWAL etal(1979)

60%

UNILATERAL

71% MERCHANT etal (1993)

68%

Page 39: Proptosis in pediatrics

DISCUSSION

RISK STUDY COMPARISON DATA

SINUSITIS 42% RODRIQUEZ etal(2000)

68%

LID & FACE INFECTION

28 % RODRIQUEZ etal(2000)

28 %

Page 40: Proptosis in pediatrics

DISCUSSION

STUDY COMPARISON DATA

INFLAMMATORY ETIOLOGY

71% SINDHU etal(1998) 39%

MAJEKODUNMI etal(NIGERIA 1982)

52%.

Page 41: Proptosis in pediatrics

DISCUSSION

STUDY COMPARISON DATA

BLOOD CULTURE

14% SEAN etal (1998) 10%

GOMEZ etal(1996).

23%

Page 42: Proptosis in pediatrics

DISCUSSION

STUDY COMPARISON DATA

SURGERY 57% NAGESWARAN etal (2006).

71%

Page 43: Proptosis in pediatrics

CONCLUSION

• NOT UNCOMMON• INFLAMMATION FROM ADJACENT SITE• CAVERNOUS SINUS THROMBOSIS

FREQUENT

HIGH MORTALITY

Page 44: Proptosis in pediatrics

CONCLUSION

• PERMANENT DEFICIT• PROTHROMBOTIC STATES COEXISTS

Page 45: Proptosis in pediatrics

CONCLUSION

EARLY & PROMPT THERAPY LEADS TO COMPLETE RECOVERY & SATISFYING OUTCOME

Page 46: Proptosis in pediatrics